BMS-986504

Resumen de Ensayos Clínicos

2 ensayos encontrados
Sobre BMS-986504

Se está recopilando información detallada sobre este medicamento.

Categoría Otros Medicamentos
2
Total Ensayos
1
Reclutando
0
Activo
0
Completado
268
Inscripción Total
14
Países
Centros activos para BMS-986504
Centros reclutando 14 países
Fase:
A Study to Evaluate the Mass Balance, Metabolism, Elimination, and Drug Levels of [14C]-BMS-986504 (MRTX1719) in Participants With Advanced Solid Tumors With Homozygous Methylthioadenosine Phosphorylase Deletion
NCT06672523 Fase 1 Reclutando 8 pacientes
Inicio: Mar 2025
Fin: Oct 2027
Intervencional
Medicamentos: BMS-986504
The purpose of this study is to evaluate the mass balance, metabolism, elimination, and drug levels of \[14C\]-BMS-986504 (MRTX1719) in participants with advanced solid tumors with homozygous methylthioadenosine phosphorylase deletion.
Hungary, Spain
Ver Detalles ClinicalTrials.gov ¿Soy elegible?
A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
NCT07492680 Fase 2 Aún no recluta 260 pacientes
Inicio: Jul 2026
Fin: May 2032
Intervencional
Medicamentos: BMS-986504 Carboplatin Daraxonrasib Gemcitabine Nab-Paclitaxel Nivolumab Paclitaxel Pemetrexed Pumitamig Temozolomide
This is an open-label, multicenter Phase 2 study evaluating BMS-986504 in participants with advanced and/or metastatic solid tumors that have MTAP deletion. The study includes a monotherapy component and a combination component in which BMS-986504 is...
United States, Belgium, Canada, China, France, Germany, Hong Kong, Ireland, Italy, Japan, Norway, So
Ver Detalles ClinicalTrials.gov ¿Soy elegible?
Volver al Glosario Ver Todos los Ensayos Filtrar Reclutando